Highlights
- Molina Healthcare shares closed at US$233.09 on 16 November 2026, up 11.27%, on Volume of 1.77 million shares.
- Third-quarter adjusted Earnings were US$0.89 per diluted share, with premium Revenue of about US$10.5 billion and membership near 4.9 million.
- Full-year 2026 guidance was reaffirmed at adjusted earnings of at least US$5.25 per share and premium revenue near US$42 billion.
- Management said plateauing medical cost trend and strong 2027 rate updates may mark the start of a Medicaid Margin turn.
A large Medicaid-focused health insurer extended its rebound on Monday. Molina Healthcare, Inc. (NYSE:MOH) closed at US$233.09 on 16 November 2026, up 11.27%, on volume of 1.77 million shares, with Market Capitalisation near US$12.2 billion. The Long Beach, California, company reported third-quarter results on 21 October 2026.
Session Snapshot
Relative volume of 1.92 shows trading well above the recent norm. The company's latest disclosed developments did not point to a single announcement on 16 November, so the move is presented as general trading activity following its third-quarter report.
Managed care shares have been sensitive in 2026 to cost trends, rate updates and enrollment changes.
Membership of about 4.9 million at 30 September 2026 spans Medicaid, Medicare and the ACA marketplace.
Third-Quarter Results
GAAP Net Income for the quarter was US$38 million, or US$0.73 per diluted share, compared with US$79 million, or US$1.51, a year earlier. Adjusted earnings were US$0.89 per share. Total revenue was about US$11.1 billion, and premium revenue fell roughly 4% to US$10.5 billion on lower Medicaid and marketplace membership, partly offset by rate updates.
The consolidated medical care ratio was 92.9%, compared with 92.6% a year earlier, with the Medicaid ratio at 93.0%.
Both revenue and adjusted earnings exceeded market expectations, although both declined from the prior year. Pre-tax margin was 0.6% against 1.0% a year earlier, and for the first nine months revenue was US$32.8 billion compared with US$34.1 billion, with Operating Cash Flow of US$629 million.
Guidance and the 2027 Outlook
Molina reaffirmed 2026 guidance of premium revenue near US$42 billion and adjusted earnings of at least US$5.25 per share, with GAAP earnings of at least US$2.38. It raised its 2026 Medicaid rate outlook while lifting its medical cost trend assumption to a range of 5% to 5.5%.
Its July outlook already included impacts from the implementation of a new Florida Medicaid contract in the fourth quarter and from its traditional Medicare Advantage prescription drug product.
Molina was awarded a new Florida Medicaid contract in November 2025 and won an Illinois Medicaid contract in June 2026, both of which feed into its longer-term membership outlook. Marketplace exposure was reduced for 2026, with segment earnings guided to at least break even.
Sector Context and Risks
Medicaid insurers have faced pressure as states reassess eligibility and as medical and pharmacy costs have risen faster than rates. Management's view that the cycle may be turning depends on rate adequacy and cost trend behaviour in coming quarters.
Investors may follow fourth-quarter results, Florida contract implementation, 2027 rate updates and the company's full 2027 guidance.
_11_17_2026_06_50_14_402066.jpg)





Please wait processing your request...